Home > Income Statement > KILITCH DRUGS (INDIA)

KILITCH DRUGS (INDIA)
Consolidated Net Profit

    Back to Income Statement
COMMUNITY POLL
for KILITCH DRUGS (INDIA)
Please provide your vote to see the results

KILITCH DRUGS (INDIA) Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Consolidated Net Profit ₹7.37 Cr₹3.67 Cr₹0.84 Cr₹3.83 Cr₹5.15 Cr

What is the latest Consolidated Net Profit of KILITCH DRUGS (INDIA) ?

The latest Consolidated Net Profit ratio of KILITCH DRUGS (INDIA) is ₹7.37 Cr based on Mar2023 Consolidated results.
Year Consolidated Net Profit
Mar2023₹7.37 Cr
Mar2022₹3.67 Cr
Mar2021₹0.84 Cr
Mar2020₹3.83 Cr
Mar2019₹5.15 Cr

How is Consolidated Net Profit of KILITCH DRUGS (INDIA) Trending?

Years Consolidated Net Profit % Change
Mar2023 ₹7.37 Cr
100.68
Mar2022 ₹3.67 Cr
335.99
Mar2021 ₹0.84 Cr
-78.02
Mar2020 ₹3.83 Cr
-25.67
Mar2019 ₹5.15 Cr -

Compare Consolidated Net Profit of peers of KILITCH DRUGS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA) ₹554.5 Cr 1.3% -1.9% 57% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹367,290.0 Cr -0.9% 0.9% 62.6% Stock Analytics
CIPLA ₹113,357.0 Cr 3.5% 4.2% 51.8% Stock Analytics
ZYDUS LIFESCIENCES ₹111,134.0 Cr 12.2% 18% 103.8% Stock Analytics
DIVIS LABORATORIES ₹104,235.0 Cr 0.8% 5.6% 19.3% Stock Analytics
DR REDDYS LABORATORIES ₹97,001.5 Cr -1% -2.4% 28.4% Stock Analytics


KILITCH DRUGS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA)

1.3%

-1.9%

57%

SENSEX

1.7%

1.5%

18.7%


You may also like the below Video Courses